ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2478

Identification of Disease-Specific Neuroimaging Phenotypes in Childhood Inflammatory Brain Diseases

Tania Cellucci1, Pascal N. Tyrrell2, Shehla Sheikh3, Suzanne Laughlin4 and Susanne M. Benseler3, 1Pediatrics/Rheumatology, The Hospital for Sick Children, Toronto, ON, Canada, 2Cardiology/Rheumatology, The Hospital for Sick Children, Toronto, ON, Canada, 3Rheumatology, The Hospital for Sick Children, Toronto, ON, Canada, 4Diagnostic Imaging, The Hospital for Sick Children, Toronto, ON, Canada

Meeting: 2012 ACR/ARHP Annual Meeting

Keywords: central nervous system involvement, Inflammation, neuroimaging and pediatric rheumatology

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Pediatric Rheumatology: Clinical and Therapeutic Disease III: Childhood Systemic Lupus Erythematosus and Other Vasculidities

Session Type: Abstract Submissions (ACR)

Background/Purpose:

Magnetic resonance imaging (MRI) is a key diagnostic modality of childhood inflammatory brain diseases (IBrainD). While overlapping clinical features contribute to significant diagnostic uncertainty, neuroimaging characteristics may provide guidance for a targeted diagnostic approach.  The aim of this study was to identify specific MRI patterns at diagnosis of distinct childhood IBrainD.

Methods:

This single centre cohort study included children less than 18 years old who were diagnosed with an IBrainD between June 1989 and December 2010 and were enrolled in the BrainWorks cohort at SickKids Hospital. All patients also had a high-quality brain MRI based on institutional protocol at diagnosis. Demographic, clinical, laboratory, neuroimaging and histologic data at diagnosis were collected.  Correspondence analysis was performed to obtain a multidimensional representation of the relationship between MRI findings and IBrainD diagnoses.  Pearson residuals (PR) were calculated to estimate the strength of associations.

Results:

A total of 142 children (51% females, median age 8.8 years) with IBrainD were identified: 104 primary angiitis of the CNS (cPACNS), 11 secondary CNS vasculitis, 8 neuronal antibody syndromes, 6 post-infectious IBrainD and 13 unclassified IBrainD. Children with angiography-positive non-progressive cPACNS were likely to have unilateral, unifocal and ischemic lesions (PR 4.2, 3.4, and 3.0, respectively). Common sites for lesions were the basal ganglia (PR 3.5), middle cerebral artery territory (PR 1.8), and internal capsule (PR 1.3). Angiography-negative cPACNS was grouped together with multifocal lesions (PR 1.64) and involvement of the leptomeninges (PR 2.3), parietal or temporal lobes (PR 1.5, 2.8), and subcortical or deep white matter (PR 2.8, 1.5). Optic neuritis (PR 2.9), volume loss (PR 1.8) and frontal lobe lesions (PR 1.5) were more likely in neuronal antibody syndromes.  Frontal lobe involvement was also seen in post-infectious IBrainD (PR 1.6).  Symmetric lesions were grouped with secondary CNS vasculitis (PR 2.0) and unclassified IBrainD (PR 2.7).

Conclusion:

Childhood inflammatory brain diseases are characterized by distinct patterns of neuroimaging findings with respect to location and type of lesion.  Identifying these patterns requires a standardized approach involving high-quality MRI for any child with suspected IBrainD.  The neuroimaging phenotype may guide further diagnostic work-up and should be incorporated into diagnostic algorithms for childhood IBrainD in the future.


Disclosure:

T. Cellucci,
None;

P. N. Tyrrell,
None;

S. Sheikh,
None;

S. Laughlin,
None;

S. M. Benseler,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2012 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/identification-of-disease-specific-neuroimaging-phenotypes-in-childhood-inflammatory-brain-diseases/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology